These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 3923162

  • 41. Hemolytic uremic syndrome.
    Camp-Sorrell D.
    Oncol Nurs Forum; 2008 Jul; 35(4):593-6. PubMed ID: 18591164
    [No Abstract] [Full Text] [Related]

  • 42. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient.
    Gordon LI, Kwaan HC.
    Semin Thromb Hemost; 1999 Jul; 25(2):217-21. PubMed ID: 10357089
    [Abstract] [Full Text] [Related]

  • 43. [Chemotherapy-associated hemolytic uremic syndrome--a case report].
    Kikuchi H, Kanamaru R.
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1927-9. PubMed ID: 1519930
    [Abstract] [Full Text] [Related]

  • 44. Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
    Boctor FN.
    Egypt J Immunol; 2006 Sep; 13(2):95-9. PubMed ID: 18689275
    [Abstract] [Full Text] [Related]

  • 45. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
    Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J, Arbus M, Woolley PV, Chiazze L, Schein PS.
    J Clin Oncol; 1989 Jun; 7(6):781-9. PubMed ID: 2497229
    [Abstract] [Full Text] [Related]

  • 46. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases.
    Giroux L, Bettez P, Giroux L.
    Am J Kidney Dis; 1985 Jul; 6(1):28-39. PubMed ID: 3927715
    [Abstract] [Full Text] [Related]

  • 47. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD, Wiley EL, Abeloff MD.
    Cancer Treat Rep; 1982 Mar; 66(3):457-61. PubMed ID: 7060035
    [No Abstract] [Full Text] [Related]

  • 48. [Three cases of drug-induced hemolytic uremic syndrome].
    Tohda S, Shiigai T, Jibiki M, Aoi T, Ueda Y, Kawasaki T, Kurokawa H, Nara N.
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
    [Abstract] [Full Text] [Related]

  • 49. Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion.
    Korec S, Schein PS, Smith FP, Neefe JR, Woolley PV, Goldberg RM, Phillips TM.
    J Clin Oncol; 1986 Feb; 4(2):210-5. PubMed ID: 3944604
    [Abstract] [Full Text] [Related]

  • 50. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
    Hayano K, Fukui H, Otsuka Y, Hattori S.
    Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
    [No Abstract] [Full Text] [Related]

  • 51. Hemolytic-uremic syndrome in a patient receiving mitomycin C and 5-fluorouracil.
    Willie GR, Levy SM, Michaels RS, Zirkin RM.
    Henry Ford Hosp Med J; 1983 Jul; 31(2):104-9. PubMed ID: 6313552
    [No Abstract] [Full Text] [Related]

  • 52. [Mitomycin-induced hemolytic-uremic syndrome].
    Zeller G, Wandel E, Schwarting A.
    Dtsch Med Wochenschr; 2003 Jun 20; 128(25-26):1399-402. PubMed ID: 12813674
    [Abstract] [Full Text] [Related]

  • 53. [Acute dyspnea following intravenous administration of vinblastine/mitomycin C].
    Lagler U, Gattiker HH.
    Schweiz Med Wochenschr; 1989 Mar 04; 119(9):290-2. PubMed ID: 2496465
    [Abstract] [Full Text] [Related]

  • 54. [Microangiopathic hemolytic anemia (MAHA) and renal failure induced by anti-neoplastic agents--a case report].
    Sagawa M, Sakuma T, Takahashi S, Usuda K, Satoh M, Kamma K, Ohta S, Nagamoto N, Imai T, Saitoh Y.
    Gan To Kagaku Ryoho; 1987 Aug 04; 14(8):2564-7. PubMed ID: 3039922
    [Abstract] [Full Text] [Related]

  • 55. Hemolytic uremic syndrome presenting after treatment of endodermal sinus tumor.
    Ogunleye DA, Lewin SN, Mutch DG, Liapis H, Herzog TJ.
    Obstet Gynecol; 2004 Nov 04; 104(5 Pt 2):1184-7. PubMed ID: 15516446
    [Abstract] [Full Text] [Related]

  • 56. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F.
    Dtsch Med Wochenschr; 2004 Jul 02; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract] [Full Text] [Related]

  • 57. Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patients.
    Bruntsch U, Groos G, Tigges FJ, Gallmeier WM.
    Eur J Cancer Clin Oncol; 1984 Jul 02; 20(7):905-9. PubMed ID: 6540191
    [Abstract] [Full Text] [Related]

  • 58. Post transfusion non-cardiogenic pulmonary edema in a patient with chemotherapy-related hemolytic uremic syndrome.
    Kluger NJ, Cummings FJ, Ready NE, Sweeney JD, Weitberg AB.
    Med Health R I; 1998 Jul 02; 81(7):235-6. PubMed ID: 9689787
    [No Abstract] [Full Text] [Related]

  • 59. Silent renal microangiography after mitomycin C therapy.
    Poch E, González-Clemente JM, Torras A, Darnell A, Botey A, Revert L.
    Am J Nephrol; 1990 Jul 02; 10(6):514-7. PubMed ID: 2127509
    [Abstract] [Full Text] [Related]

  • 60. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents.
    Murgo AJ.
    Semin Hematol; 1987 Jul 02; 24(3):161-77. PubMed ID: 3310241
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.